SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-17-031903
Filing Date
2017-05-11
Accepted
2017-05-11 16:10:35
Documents
45
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a17-9935_110q.htm 10-Q 421849
2 EX-31.1 a17-9935_1ex31d1.htm EX-31.1 10623
3 EX-31.2 a17-9935_1ex31d2.htm EX-31.2 10629
4 EX-32.1 a17-9935_1ex32d1.htm EX-32.1 7012
  Complete submission text file 0001104659-17-031903.txt   2148544

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT rarx-20170331.xml EX-101.INS 363705
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rarx-20170331.xsd EX-101.SCH 26340
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rarx-20170331_cal.xml EX-101.CAL 27424
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rarx-20170331_def.xml EX-101.DEF 75040
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT rarx-20170331_lab.xml EX-101.LAB 215453
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rarx-20170331_pre.xml EX-101.PRE 155627
Mailing Address 87 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 87 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 (617) 401-4060
Ra Pharmaceuticals, Inc. (Filer) CIK: 0001481512 (see all company filings)

IRS No.: 262908274 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37926 | Film No.: 17834387
SIC: 2834 Pharmaceutical Preparations